Pavan Cheruvu, Sio Gene Therapies outgoing CEO
Biotech's very bad start to the year continues as microcap gene therapy player Sio ditches CEO, lead partnership
In a biotech market hit from top to bottom by dwindling investor sentiment, small firms, in particular, are bearing the brunt of the burden. Now …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
